Dr Chris Booth

Dr. Chris Booth is a seasoned professional with extensive experience in the biotech and investment sectors. Currently serving as Non-Executive Director and Co-founder at Boomerang Biopathways Pty Ltd, Dr. Booth focuses on accelerating clinical outcomes for BioPharma and MedTech companies by leveraging Australia's advantages in clinical trial services. As an Investment Partner at 42 Ventures and an Advisor at Gallantree and N-Strategy Consulting Services, Dr. Booth supports innovative companies' growth and international expansion. With a background in business development through roles at Emadin sa/nv and previous companies, including Quæfacta Health and Memtech Group, Dr. Booth combines a strong educational foundation in Immunology and Biotechnology with finance acumen, holding degrees from UNSW, Deakin University, FINSIA, and The University of Queensland.